Statistics

Total Visits

Views
Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS27

Select a period of time:

Number of views in the range

Views
Real-world use of cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) PREVIOUSLY TREATED WITH DOCETAXEL: REGIONAL ANALYSIS4

Views

Views
June 20250
July 20250
August 20250
September 20252
October 20250
November 20252
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States2
Brazil1
Turkey1
 

Top cities views

Views
Istanbul1
Uberaba1